Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$140K Sell
937
-1,019
-52% -$212K 0.02% 546
2021
Q2
$480K Buy
1,956
+840
+75% +$220K 0.06% 194
2021
Q1
$295K Buy
1,116
+621
+125% +$175K 0.03% 301
2020
Q4
$145K Sell
495
-14
-3% -$3.59K 0.02% 559
2020
Q3
$125K Sell
509
-70
-12% -$15.9K 0.02% 596
2020
Q2
$115K Sell
579
-688
-54% -$128K 0.01% 607
2020
Q1
$233K Sell
1,267
-370
-23% -$65.8K 0.03% 298
2019
Q4
$273K Buy
1,637
+328
+25% +$48.8K 0.03% 361
2019
Q3
$171K Buy
+1,309
New +$170K 0.02% 525

Other funds holding AMED

First Mercantile Trust's AMED Position: Q3 2021 in Review

First Mercantile Trust reduced its Amedisys (AMED) stake by 52% in Q3 2021, selling an estimated $212K and leaving 937 shares worth $140K. The position accounts for 0.02% of the portfolio, ranked #546.

First Mercantile Trust first reported a position in AMED in Q3 2019 and has held it in 9 quarters since. The position peaked at $480K in Q2 2021. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • First Mercantile Trust held 937 shares of Amedisys worth $140K as of Q3 2021.
  • First Mercantile Trust sold 1,019 Amedisys shares in Q3 2021, an estimated $212K.
  • Amedisys made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #546 holding.
  • First Mercantile Trust first reported a position in Amedisys in Q3 2019 and has held it in 9 quarters since.
  • First Mercantile Trust's Amedisys position peaked at $480K in Q2 2021.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.